Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2023, 5(7); doi: 10.25236/IJFM.2023.050709.

The Research Progress of Traditional Chinese Medicine in the Treatment of Liver Cancer Based on the Microenvironment


Zhenping Ouyang1, Jianhua Ke1, Yuanyuan Dang2, Jin Zheng2

Corresponding Author:
Zhenping Ouyang

1Shaanxi University of Chinese Medicine, Xianyang, China

2The Second Hospital Affiliated to Air Force Medical University, Xi'an, China


Liver cancer is a common malignancy of the digestive system. The microenvironment of liver cancer is an important factor affecting tumor recurrence and metastasis. Traditional Chinese medicine believes that the etiology of liver cancer is complex, the types of symptoms are variable, and there are many treatments. Traditional Chinese medicine compounds, single drugs, etc. can affect the microenvironment of liver cancer by regulating signaling pathways and cell proliferation. This article aims to review the impact of traditional Chinese medicine on the microenvironment of liver cancer.


traditional Chinese medicine; hepatocarcinoma; tumor microenvironment

Cite This Paper

Zhenping Ouyang, Jianhua Ke, Yuanyuan Dang, Jin Zheng. The Research Progress of Traditional Chinese Medicine in the Treatment of Liver Cancer Based on the Microenvironment. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 7: 57-62. https://doi.org/10.25236/IJFM.2023.050709.


[1] Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China[J]. Cancer Letters, 2018, 412: 283-288. 

[2] Zhang Q, Lou Y, Bai XL, Liang TB. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression. World J Gastroenterol. 2018; 24(31): 3500-3512. 

[3] Yang Lihui, Hu Kaiwen, Wang Jingxiao. Exploring the mechanism of blood circulation and phlegm detoxification in liver cancer based on the immune microenvironment of liver cancer[J]. Chinese Journal of Experimental Medical Formulae, 2022, 28(14):172-178. )

[4] Li J, Lin HS. Integrative medicine: a characteristic China model for cancer treatment. Chin J Integr Med. 2011; 17(4):243-245. 

[5] Hao Y, Li D, Xu Y, et al. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data[J]. BMC Bioinformatics, 2019, 20(S7). 

[6] Gao Q, Qiu S J, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection[J]. J Clin Oncol, 2007, 25(18):2586-2593. 

[7] Jiang R, Tang J, Chen Y, et al. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion[J]. Nature Communications, 2017, 8(1). 

[8] Liu X, Li M, Wang X, et al. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma. Phytomedicine. 2019; 62:152930. 

[9] Hao Y, Li D, Xu Y, et al. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data[J]. BMC Bioinformatics, 2019, 20(S7). 

[10] Gao Q, Qiu S J, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection [J]. J Clin Oncol, 2007, 25(18): 2586-2593. 

[11] Wu J, Li J, Salcedo R, et al. The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma [J]. Cancer Research, 2012, 72(16): 3977-3986. 

[12] Tian Z, Hou X, Liu W, et al. Macrophages and hepatocellular carcinoma. Cell Biosci 2019; 9. 

[13] Chen Z, Yu M, Yan J, et al. PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology [J]. Frontiers in Immunology, 2021, 12. 

[14] Biffi G, Tuveson DA. Diversity and Biology of Cancer-Associated Fibroblasts. Physiol Rev. 2021; 101(1): 147-176. 

[15] Liu J, Chen S, Wang W, et al. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways [J]. Cancer Letters, 2016, 379(1): 49-59. 

[16] Gurzu S, Kobori L, Fodor D, Jung I. Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review. Biomed Res Int. 2019; 2019:2962580. Published 2019 Sep 29. 

[17] Yoshimatsu Y, Wakabayashi I, Kimuro S, et al. TNF-α enhances TGF-β-induced endothelial-to- mesenchymal transition via TGF-β signal augmentation. Cancer Sci. 2020; 111(7): 2385-2399. 

[18] Biffi G, Oni TE, Spielman B, et al. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Cancer Discov. 2019; 9(2):282-301. 

[19] De Sanctis F, Ugel S, Facciponte J, Facciabene A. The dark side of tumor-associated endothelial cells. Semin Immunol. 2018; 35:35-47. 

[20] Hida K, Maishi N, Annan DA, Hida Y. Contribution of Tumor Endothelial Cells in Cancer Progression. Int J Mol Sci. 2018 Apr 24; 19(5):1272. 

[21] Zhou Y, Li Y, Xu S, et al. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3. Int J Cancer. 2020; 146(5):1383-1395. 

[22] Sakano Y, Noda T, Kobayashi S, et al. Tumor endothelial cell-induced CD8+ T-cell exhaustion via GPNMB in hepatocellular carcinoma. Cancer Sci. 2022; 113(5):1625-1638. 

[23] Singh M, Lima A, Molina R, et al. Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models. Nat Biotechnol. 2010; 28(6):585-593. 

[24] Hsieh CC, Hung CH, Chiang M, Tsai YC, He JT. Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling. Int J Mol Sci. 2019; 20(20):5079. Published 2019 Oct 13. 

[25] Ning J, Ye Y, Bu D, et al. Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness. Mol Ther. 2021; 29(6):2067-2087. 

[26] Dhar D, Baglieri J, Kisseleva T, Brenner DA. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood). 2020; 245(2):96-108. 

[27] Mouw JK, Ou G, Weaver VM. Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol. 2014; 15(12):771-785. 

[28] Yu Simiao, Li Ping, Li Yuan, et al. The prevention and treatment of liver cirrhosis is discussed from "seeing liver disease, knowing the liver to the spleen, and practicing the spleen first"[J]. Journal of Beijing University of Chinese Medicine, 2022, 45(01):29-33. 

[29] Li J, Li L, Liu R, Lin HS. Establishing Chinese medicine characteristic tumor response evaluation system is the key to promote internationalization of Chinese medicine oncology. Chin J Integr Med. 2012; 18(10):730-736. 

[30] Feng Xiaoyi. Study on anti-liver cancer efficacy and mechanism of action of Gansui Banxia Tang [D]. Kunming University of Science and Technology, 2022. 

[31] Chen Liang. In vitro experimental study of Gansui root extract on human epithelioid liver carcinoma BEL-7402[J]. Northwestern Botanical Journal, 2008(09):1889-1892. 

[32] Fan L, Zhu H, Tao W, et al. Euphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3. Phytomedicine. 2019; 62:152931. 

[33] Tan Zhangbin, Xu Youcai, Liu Qi. Rhubarb extract activates p38MAPK to promote apoptosis in HepG2 hepatoma cells [J]. Modern Digestive and Interventional Diagnosis and Treatment, 2022, 27(08): 970-973+978. 

[34] Wang Mengqi, Lin Haihong, Du Gangjun. Antitumor effect and mechanism of morning glory decoction on subcutaneous transplanted tumors of H22 liver cancer in mice [J]. Journal of Henan University (Medical Sciences), 2019, 38(02):77-84. 

[35] Yuan Q, Yao F, Zhou L, et al. Yu Ping Feng San Exert Anti-Angiogenesis Effects through the Inhibition of TSLP-STAT3 Signaling Pathways in Hepatocellular Carcinoma. Evid Based Complement Alternat Med. 2019; 2019: 1947156. Published 2019 Oct 23. 

[36] Si Hayong, Zhang Jie, Ma Yiming, et al. Experimental study on inhibition of proliferation and apoptosis of H22 hepatoma cells by regulating cancer-associated fibroblasts [J]. Journal of Integrative Medicine and Liver Diseases, 2022, 32(10):907-911. 

[37] Zhou Jueyi, Feng Jihong, Zhao Liping, et al. Clinical study of spleen detoxification decoction combined with hepatic artery chemoembolization in the treatment of primary liver cancer[J]. New Chinese Medicine, 2023, 55(02):115-118. 

[38] Wu SY, Cui SC, Wang L, et al. 18β-Glycyrrhetinic acid protects against alpha- naphthylisothiocyanate-induced cholestasis through activation of the Sirt1/FXR signaling pathway. Acta Pharmacol Sin. 2018; 39(12):1865-1873. 

[39] Zhang QB, Meng XT, Jia QA, et al. Herbal Compound Songyou Yin and Moderate Swimming Suppress Growth and Metastasis of Liver Cancer by Enhancing Immune Function. Integr Cancer Ther. 2016; 15(3):368-375. 

[40] Chen Tt, Du Sl, Wang Sj, Wu L, Yin L. Dahuang Zhechong pills inhibit liver cancer growth in a mouse model by reversing Treg/Th1 balance. Chin J Nat Med. 2022; 20(2):102-110. 

[41] Zheng P, Huang Z, Tong DC, et al. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022; 14(2):450-477. 

[42] Suh J, Kim DH, Surh YJ. Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Arch Biochem Biophys. 2018; 643: 62-71.